Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G for Xencor Inc Common Stock, par value $0.01 per share (XNCR).
- Disclosed ownership: 6.5%.
- Date of event: 09 Oct 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 6.5% ownership in Xencor Inc Common Stock, par value $0.01 per share (XNCR) on 09 Oct 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 3.5% | 2,467,127 | 0 | 2,467,127 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 3.5% | 2,467,127 | 0 | 2,467,127 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 2.5% | 1,793,209 | 0 | 1,793,209 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 2.5% | 1,793,209 | 0 | 1,793,209 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.4% | 286,542 | 0 | 286,542 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.4% | 286,542 | 0 | 286,542 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 6% | 4,260,336 | 0 | 4,260,336 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 6.5% | 4,619,341 | 0 | 4,619,341 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 6.5% | 4,619,341 | 0 | 4,619,341 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 6.5% | 4,619,341 | 0 | 4,619,341 | /s/ Mark N. Lampert | Mark N. Lampert |